DIRS.INFO The most relevant business & tech news

Morgan Stanley raised its price target on Nvidia, calling for more than 15% upside going forward. — Lisa Kailai Han 5:53 a.m.: Jefferies lowers Tesla price target, cites 'self-inflicted' wounds Tesla's troubles may not be over yet, according to Jefferies. The investment firm kept its hold rating on the electric vehicle maker and lowered its price target to $165 from $185. Jefferies analyst Philippe Houchois also said Tesla is plagued by shifting product priorities. — Lisa Kailai Han 5:53 a.m.: Morgan Stanley raises Nvidia price target Nvidia has already rallied more than 72% in 2024.

Persons: Morgan Stanley, Jefferies, Patrick Cunningham, Erik Fyrwald's, Cunningham, — Lisa Kailai Han, Zillow, John Colantuoni, Colantuoni, Scott Schoenhaus, Schoenhaus, Lisa Kailai Han, Hess, Betty Jiang, CVX, Jiang, Tesla, Philippe Houchois, Joseph Moore, Moore, — Fred Imbert Organizations: CNBC, Nvidia, Citi, Management, & Biosciences, Jefferies, National Association of Realtors, Markets, GDRX, Barclays, Chevron, NVIDIA, AMD Locations: Tuesday's, China

☆ Here are Wednesday's biggest analyst calls: Nvidia, Tesla, Exxon, Coinbase, Cava, Alphabet, Amazon, Block & more
▼ + stars: | 2024-04-10 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Bank of America reiterates Nvidia as buy Bank of America said it's sticking with the stock as a top pick. Mizuho reiterates Block as buy Mizuho raised its price target on the payment company to $106 per share from $99. Bank of America reiterates Coinbase as underperform. Bank of America reiterates Alphabet as buy Bank of America said "AI innovation [was] on display" at the company's Google Cloud Next event. " Deutsche Bank reiterates Amazon as buy Deutsche said the company is a top pick heading into earnings. "

Persons: Morgan Stanley, Piper Sandler, Tesla, Piper, Zillow, Jefferies, Mizuho, Goldman Sachs, Goldman, TD Cowen, Cowen, William Blair, Vital, Canaccord, Truist Organizations: NVIDIA, " Bank of America, Nvidia, Bank of America, Jefferies, Mizuho, SEC, Barclays, Google, Citi, Pharma, Chevron, Exxon, Vital, Argus, Motors, of America, Deutsche Bank, Amazon, Deutsche, E Corp, National, CN Locations: FCFS, Cava, CAVA, Albemarle, 1Q24, OW

☆ Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Super Micro Computer, Disney, Netflix, Meta, Amazon & more
▼ + stars: | 2024-03-25 | by ( Michael Bloom | ) www.cnbc.com time to read: +7 min

Wells Fargo reiterates Citi as overweight Wells Fargo raised its price target on Citi to $80 per share from $70." "We initiate coverage of Kinetik Holdings Inc. with an Outperform rating and $40 price target." "We are initiating coverage of Motorola Solutions (MSI) with an Outperform rating and $400 Target price." Citi reiterates Netflix as neutral Citi raised its price target on Netflix to $660 per share from $555. Morgan Stanley reiterates Tesla as overweight Morgan Stanley said it's standing by its overweight rating on the stock.

Persons: BoB, Mizuho downgrades Tesla, Wells, Wells Fargo, Kinetik, it's bullish, Huya, Raymond James downgrades Dave, Raymond James, Dave, Buster's, Morgan Stanley, it's, Evercore, Sealy, Raymond James downgrades Scotts, Tesla, MASI Organizations: Bank of America, Nvidia, Mizuho, Citi, RBC, Kinetik Holdings, Northland, Astera, of America, " Bank of America, Meta, Argus, Barclays, Adobe, ISI, Motorola Solutions, Netflix, Mattress, JPMorgan, PT, Raymond James downgrades Scotts Miracle, Gro, Scotts Miracle, Strong, MASI, UBS, Apple, Arista Networks, Arista Locations: China

Goldman Sachs lowered its rating on Estée Lauder to neutral, and its new price target calls for a slight decline going forward. Elsewhere, Daiwa raised its price target on Nvidia, which points to more than 10% upside over the next 12 months. The firm stood by its outperform rating on the chipmaker stock, but lifted its price target to $900 from $535. FLYW YTD mountain FLYW in 2024 Faucette accompanied his downgrade by lifting his price target to $30 from $27. He also lifted his price target on the stock to $40 from $30, implying upside of 24.6% from Thursday's close.

Persons: Goldman Sachs, Estée Lauder, Jefferies, Root, Daiwa, Brad Sills, Sills, — Lisa Kailai Han, Stephens, Vita Coco, Coco, Jim Salera, COCO, Lisa Gill, Gill, Louis Miscioscia, Miscioscia, Lisa Kailai Han, Piper Sandler downgrades, Piper Sandler, Mark Fitzgibbon, Fitzgibbon, Morgan Stanley downgrades Flywire, Morgan Stanley, James Faucette, Faucette, Goldman Sachs downgrades Estée Lauder, Lauder, Goldman, Yaron Kinar, Kinar, Fred Imbert Organizations: CNBC, Nvidia, Bank of America, of America, Vertex, Accenture, RSM, BDO, JPMorgan, Daiwa, Markets, Riding, AMD, Intel, York Community Bancorp, York Community, New York Community Bancorp, Travel, B2B, U.S, Jefferies Locations: York, Canada, Asia, China, Hainan, Thursday's

☆ GoodRx to offer Sanofi's insulin injection for only $35
▼ + stars: | 2023-10-19 | by ( ) www.reuters.com time to read: +1 min

A pharmacist holds a box of the drug Lantus SoloStar, made by Sanofi Pharmaceutical, at a pharmacy in Provo, Utah, U.S. January 9, 2020. This collaboration comes after Novo Nordisk (NOVOb.CO) , Eli Lilly (LLY.N) and Sanofi pledged in March to lower the list prices of many of their insulin products by 70%-78% later in the year or in 2024. Americans with insurance typically pay a fraction of the list prices for prescription drugs, but uninsured people sometimes have to pay the full price, forcing some to ration or skip taking their medicine. About 8.4 million of the 37 million people with diabetes in the U.S. use insulin, according to the American Diabetes Association. Reporting by Khushi Mandowara in Bengaluru; Editing by Shweta AgarwalOur Standards: The Thomson Reuters Trust Principles.

Persons: SoloStar, George Frey, GoodRx, Eli Lilly, Khushi, Shweta Agarwal Organizations: Sanofi Pharmaceutical, REUTERS, Sanofi, U.S ., Novo Nordisk, Novo, American Diabetes Association, Thomson Locations: Provo , Utah, U.S, Lilly, Bengaluru

☆ On tap next week: Two key inflation reports and 4 Club earnings releases. Here's what we're looking for
▼ + stars: | 2023-08-05 | by ( Zev Fima | ) www.cnbc.com time to read: +7 min

Economic releases : The Labor Department releases its monthly consumer price index and producer price index on Thursday and Friday, respectively. For that reason, we'd be content if the July figure doesn't indicate a resurgence of rising wholesale costs, which is a concern given a recent uptick in energy prices. On Tuesday before the opening bell, Club holding Eli Lilly (LLY) reports. Finally, Club names Walt Disney (DIS) and Wynn Resorts (WYNN) will report on Wednesday after the closing bell. In preparation for these releases, be sure to check out our first-quarter earnings report card .

Persons: we'll, Knight, Eli Lilly, We'll, donanemab, Walt Disney, We're, Tyson, Henry Schein, Li Auto, Armour, WEN, Ralph Lauren, Price, Jim Cramer's, Jim Cramer, Jim, Spencer Platt Organizations: Nasdaq, Labor Department, Reserve, Manufacturing, ADP, Fitch, AAA, U.S ., PPI, Coterra Energy, Walt, Wynn Resorts, Disney, Tyson Foods, TSN, KKR, Energy, Paramount, UPS, Barrick, Duke Energy, Restaurant Brands, Warner Music, Fox Corp, NRG Energy, AMC, Bros, Endeavor, IAC, Sony, SONY, Brookfield Asset Management, WYNN, Trade, Novo Nordisk, US Foods, News Corp, Air Canada, Jim Cramer's Charitable, CNBC, Traders, New York Stock Exchange, Getty Locations: United States, Mounjaro, Hollywood, Las Vegas, Boston, Macao, PENN, Valvoline, VVV, Credicorp, New York City

☆ Here are Monday's biggest analyst calls: Apple, Nvidia, Tesla, Amazon, Chevron, Walmart, Adobe & more
▼ + stars: | 2023-07-31 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Here are Monday's biggest calls on Wall Street: Goldman Sachs upgrades Chevron to buy from neutral Goldman said it sees a cash flow inflection for the oil and gas giant. Morgan Stanley names Keurig Dr Pepper a top pick Morgan Stanley said the beverage giant is its new top pick. Morgan Stanley reiterates Walmart as overweight Morgan Stanley said Walmart+ continues grow and gain new members. Morgan Stanley downgrades Salesforce to equal weight from overweight Morgan Stanley said positive catalysts are in the "rear-view mirror" for the stock. Morgan Stanley upgrades Adobe to overweight from equal weight Morgan Stanley said in its upgrade of Adobe that it sees generative AI driving creativity.

Persons: Goldman Sachs, Goldman, Bernstein, Morgan Stanley, Dr Pepper, Jefferies, Carvana, there's, Cowen, Piper Sandler, Apple, Piper, JPMorgan downgrades, it's, Ford, Oppenheimer, Evercore, Morgan Stanley downgrades Salesforce, Tesla Organizations: Chevron, Nvidia, Apple, Walmart, JPMorgan, JPMorgan downgrades Penske, " Bank of America, Hasbro, of America, Deutsche Bank, York Community, Deutsche, RBC, CSX, Electric, GE, Triple, SG, Wayfair, Suisse, UPS, Credit Suisse, Teamsters, Adobe, Barclays, EV, Detroit Locations: China, York

☆ GoodRx pays $1.5 million to settle health privacy allegations
▼ + stars: | 2023-02-01 | by ( ) www.reuters.com time to read: +1 min

WASHINGTON, Feb 1 (Reuters) - U.S. healthcare firm GoodRx Holdings (GDRX.O) has agreed to pay $1.5 million to settle allegations that it failed to notify customers that it shared personal health information with Alphabet's (GOOGL.O) Google, Meta's (META.O) Facebook and others, the Federal Trade Commission said on Wednesday. Under the terms of the settlement, GoodRx will be barred from sharing user health data with other companies to use for advertising. "Digital health companies and mobile apps should not cash in on consumer’s extremely sensitive and personally identifiable health information," said Samuel Levine, director of the FTC's Bureau of Consumer Protection, in a statement. The settlement is the first under the FTC's Health Breach Notification Rule, the agency said. GoodRx promised users it would never share health information with advertisers but gave information to Google, Facebook, Criteo and others, the agency said in their complaint.

☆ GoodRx is a buy that can surge 60% from here, Citi says
▼ + stars: | 2022-12-01 | by ( Sarah Min | ) www.cnbc.com time to read: +1 min

The sell-off in telemedicine name GoodRx is overdone, and now is a good time to buy the stock, according to Citi. "In our view, GDRX will continue to serve a vital role in bringing transparency/consumerism to a historically unshopable market," Grosslight wrote in a Wednesday note. In addition to its focus on generic retail prescription drugs, GoodRx has recently expanded into branded Rx spending as well. the recently announced ESI partnership for commercial members)," Grosslight wrote. "In our view, the market has been too punitive, effectively pricing in no terminal value," he added.

☆ Here are Thursday's biggest analyst calls: Apple, Amazon, Tesla, Chipotle, Capital One, United & more
▼ + stars: | 2022-12-01 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Morgan Stanley downgrades Capital One and Ally Financial to underweight from equal weight Morgan Stanley said in its downgrade of Capital One and Ally Financial that it sees "significant risk" for both stocks. Morgan Stanley reiterates Tesla as overweight Morgan Stanley said it's standing by it's overweight rating on Tesla but is concerned 2023 could be a disappointing year in general for electric vehicles. Morgan Stanley initiates Vizio as equal weight Morgan Stanley said it's concerned the television tech company lacks scale to keep up with bigger competitors. Morgan Stanley reiterates Salesforce as overweight Morgan Stanley said it's standing by shares of Salesforce after the company's disappointing earnings report on Wednesday. Morgan Stanley reiterates Snowflake as overweight Morgan Stanley said investors should stick with shares of Snowflake for the long-term after its earnings report on Wednesday.

Search resuls for: "GDRX"

10 mentions found